FEP 7.01.113 Bioengineered Skin and Soft Tissue Substitutes

FEP 7.01.113 Bioengineered Skin and Soft Tissue Substitutes. The policies contained in the FEP Medical Policy Manual are developed to assist ...

FEP 7.01.113 Bioengineered Skin and Soft Tissue Substitutes. The policies contained in the FEP Medical Policy Manual are developed to assist in administering ...

7.01.113 Bioengineered Skin and Soft Tissue Substitutes

Bioengineered skin and soft tissue substitutes are artificial alternatives to live skin grafts for wound care and tissue reconstruction.

7.01.113 Bioengineered Skin and Soft Tissue Substitutes

Some state or federal mandates (e.g., Federal Employee Program [FEP]) prohibits plans from denying Food and Drug Administration (FDA)-approved technologies ...

Subject: Bio-Engineered Skin and Soft Tissue Substitutes

Federal Employee Program (FEP): Follow FEP guidelines. State ... 7.01.113 BioEngineered Skin and Soft Tissue Substitutes, 02/24. 18 ...

Bioengineered Skin and Soft Tissue Substitutes, Amniotic ...

Blue Cross and Blue Shield Association Medical Policy MPRM 7.01.113 Bioengineered. Skin and Soft Tissue Substitutes. Last reviewed May 2024. Accessed July ...

Prior Authorization Request Form Standard Fax Number

7.01.113 Bioengineered Skin and Soft Tissue Substitutes. Page 2. 20230420. Page ... For questions: Call FEP Authorization Requests Phone Number: 1 (800) 633-4581.

Bioengineered Skin and Soft Tissue Substitutes and Amniotic ...

Blue Cross and Blue Shield Association Medical Policy MPRM 7.01.113 Bioengineered ... Federal Employee Program (FEP): Members may have ...

MP 7.01.113 - Bioengineered Skin and Soft Tissue Substitutes

Our medical policies are designed for informational purposes only and are not an authorization, explanation of benefits or a contract.

Bioengineered Skin and Soft Tissue Substitutes and Amniotic Products

For the specific amniotic membrane grafts and bioengineered skin and soft tissue substitutes listed above (Criteria I.-VI.), all other uses are ...

Bio-Engineered Skin and Soft Tissue Substitutes - AAPC

Bio-Engineered Skin and Soft Tissue Substitutes. Policy Number: 7.01.113. Last Review: 3/2014. Origination: 4/2008. Next Review: 3/2015. Policy.

Bio-Engineered Skin and Soft Tissue Substitute minor 3-25-14 - AAPC

... FEP Medical. Policy Manual MP-7.01.113 Allograft Use in Breast Reconstruction Surgery. The FEP. Medical Policy manual can be found at: www.fepblue.org. III ...

Skin and Soft Tissue Substitutes | Blue Cross NC

Other situations in which bioengineered skin products might substitute for living skin grafts include certain postsurgical states (e.g., breast ...

Surgery - Blue Cross of Idaho

7.01.113. Bioengineered Skin and Soft Tissue Substitutes. 7.01.118. Surgical Treatment of Femoroacetabular Impingement. 7.01.120. Facet Arthroplasty. 7.01.121.

663 Bioengineered Skin and Soft Tissue Substitutes

BCBSA Reference Number: 7.01.113 (For Plan internal use only). NCD/LCD: N/A. Related Policies. Amniotic Membrane and Amniotic Fluid, #643. Policy1. Commercial ...

Skin and Soft Tissue Substitutes - UHCprovider.com

Skin substitutes also known as bioengineered, tissue-engineered, or artificial skin, are a mixed group of biologic, synthetic, or biosynthetic ...

Skin Substitutes for Treating Chronic Wounds: Technical Brief - CMS

Manufacturers self- determine whether their human cells, tissues, or cellular or tissue-based product (HCT/P) can be marketed without FDA ...

Skin and Soft Tissue Substitutes - Medical Clinical Policy Bulletins

Bioengineered skin and soft tissue substitutes are cellular or acellular matrices and can be derived from human tissue (autologous or allogeneic), nonhuman ...

Medical Policies Recent Updates | Provider - Premera Blue Cross

7.01.113 Bioengineered Skin and Soft Tissue Substitutes, Coding update. Added new HCPCS codes A2027, A2028, A2029. 7.01.113, 06/01/2024, 10/01/2024. 7.01.147 ...

Medical Policy - Bioengineered Skin and Soft Tissue Substitutes

Treatment of chronic, noninfected, full-thickness diabetic lower extremity ulcers using the following tissue- engineered skin substitutes may be ...